Ohio Right to Life Celebrates Passage of Pro-Life Bills
Legislation would require education on fetal development
and prohibit the mail-order sale of abortion drugs
COLUMBUS – Ohio Right to Life today celebrated the passage of two pro-life bills out of the Ohio House of Representatives.
House Bill 324, the Patient Protection Act, would prohibit the mail-order sale and remote prescribing of dangerous drugs that cause severe side effects in more than five percent of patients. The abortion drug mifepristone would be classified as a dangerous drug, meaning a woman would be required to make an in-person visit to her doctor and be informed of the dangerous side effects before taking the abortion pill.
House Bill 485, the Baby Olivia Act, would require Ohio public schools to provide human growth and development instruction in health education, including an ultrasound video and “Meet Baby Olivia,” which is a 3-minute, sophisticated video animation that illustrates the amazing growth and development of the unborn child from fertilization to birth.
The Patient Protection Act passed 59-28 and the Baby Olivia Act passed 58-26. Ohio Right to Life supported both bills.
“The bills that passed today are common sense, broadly supported ideas. Showing students how a baby grows in the womb isn’t and shouldn’t be controversial. It’s simply science. Protecting patients from drugs that do a tremendous amount of harm to both mother and obviously the unborn baby, by just returning to the standard originally set by the FDA requiring oversight and follow up with a doctor, is beyond reasonable,” said Carrie Snyder, Executive Director of Ohio Right to Life. “We are very thankful that Ohio’s representatives in the House acted with the interests of Ohio’s mothers and children in mind today. We look forward to working with the Senate to pass these bills in 2026.”